PPA
PCVX icon

Parametric Portfolio Associates’s Vaxcyte PCVX Stock Holding History

Parametric Portfolio Associates’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-9,565
Closed -$228K – 3744
2021
Q4 		$228K Sell
9,565
-2,976
-24% -$69.2K ﹤0.01% 3378
2021
Q3 		$318K Sell
12,541
-13,437
-52% -$326K ﹤0.01% 3277
2021
Q2 		$585K Buy
+25,978
New +$532K ﹤0.01% 3017
2021
Q1 		– Sell
-35,663
Closed -$948K – 4077
2020
Q4 		$948K Buy
35,663
+16,769
+89% +$623K ﹤0.01% 3078
2020
Q3 		$933K Buy
+18,894
New +$752K ﹤0.01% 2965

Other funds holding PCVX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
MVM
Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return